Results for tag: "Kevzara"

Kevzara is a drug used to treat immune disorders, such as rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis. It is a monoclonal antibody that works by blocking the activity of a protein called interleukin-6 (IL-6). Kevzara is administered by subcutaneous injection and is approved for use in adults. It is used to reduce signs and symptoms of active rheumatoid arthritis, as well as to improve physical function and delay progression of structural damage. Kevzara is part of a growing market of immune disorder drugs, which includes biologics, small molecules, and other treatments. These drugs are used to treat a variety of conditions, including autoimmune diseases, inflammatory diseases, and allergies. The market is expected to grow in the coming years, driven by increasing prevalence of immune disorders and the development of new treatments. Companies in the Kevzara market include Sanofi, Regeneron Pharmaceuticals, AbbVie, and Bristol-Myers Squibb. Show Less Read more